WuXi Biologics collaborates with Sinorda Biomedicine for antibody development
Solvonis expands SVN-015 into depression following positive preclinical data
Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE
Glaukos receives FDA approval for repeat administration of iDose TR
Bio-Techne launches ultra-sensitive neurodegenerative disease assays on Ella platform
MedPal AI announces approval to supply Eli Lilly medicines in UK
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme
Insilico Medicine agrees drug development collaboration with Qilu Pharmaceutical Group
United Therapeutics reports positive phase 1 data for bioengineered liver in acute liver failure
Sarepta reports positive three-year EMBARK results for ELEVIDYS in ambulatory Duchenne patients
BioArctic partner Eisai secures FDA priority review for Leqembi Iqlik subcutaneous starting dose
Scancell secures FDA clearance for Phase 3 melanoma trial of iSCIB1+
BioCryst Pharmaceuticals acquires Astria Therapeutics
Insilico Medicine's ISM8969 receives US FDA IND approval for Parkinson's Disease